ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE

被引:87
作者
HIRSH, J
DALEN, JE
DEYKIN, D
POLLER, L
机构
[1] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA
[2] WITHINGTON HOSP, NATL REFERENCE LAB ANTICOAGULANT REAGENT & CONTROL, MANCHESTER M20 8LR, LANCS, ENGLAND
[3] VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA
关键词
D O I
10.1378/chest.102.4.312S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:S312 / S326
页数:15
相关论文
共 132 条
  • [1] ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427
  • [2] HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON
    ALVING, BM
    STRICKLER, MP
    KNIGHT, RD
    BARR, CF
    BERENBERG, JL
    PECK, CC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) : 499 - 501
  • [3] BAILEY EL, 1971, CAN MED ASSOC J, V105, P1041
  • [4] BECHTOLD H, 1984, THROMB HAEMOSTASIS, V51, P358
  • [5] BELL RG, 1978, FED PROC, V37, P2599
  • [6] VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL
    BERN, MM
    LOKICH, JJ
    WALLACH, SR
    BOTHE, A
    BENOTTI, PN
    ARKIN, CF
    GRECO, FA
    HUBERMAN, M
    MOORE, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) : 423 - 428
  • [7] BOROWSKI M, 1986, J BIOL CHEM, V261, P4969
  • [8] BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424
  • [9] BRECKENRIDGE A, 1978, SEMIN HEMATOL, V15, P19
  • [10] BROEKMANS AW, 1983, THROMB HAEMOSTASIS, V49, P251